The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.

The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.

The company will compete with a device Boston Scientific acquired for $850 million.

Speaker Mike Johnson negotiated a number of last minute changes to the megabill to get it across the finish line, including moving up the start date for Medicaid work requirements.